Abstract
Background:
Endothelin-1 (ET-1) and Rho-kinase (ROCK) increase vascular tone in experimental persistent pulmonary hypertension of the newborn (PPHN). Whether ET-1 activates ROCK to decrease angiogenesis in the developing lung remains unknown.
Methods:
Proximal pulmonary artery endothelial cells (PAECs) were harvested from fetal sheep after partial ligation of the ductus arteriosus in utero (PPHN) and controls. Growth and tube formation were assessed after ET-1 treatment. The effect of ET-1 antagonism on tube formation was studied using ET-1 small interfering RNA (siRNA), ET-1 monoclonal antibodies (ET-1mAbs), BQ-123 (an ETA blocker), and bosentan (an ETA/ETB blocker). ET-1 gene and protein and ETA/ETB receptor protein expression were measured in normal and PPHN PAECs. ET-1–ROCK interactions were assessed by measuring ROCK activity after ET-1, ET-1 siRNA, and bosentan treatments, and tube formation with ET-1 and Y-27632 (ROCK inhibitor).
Results:
ET-1 did not affect growth but decreased tube formation in normal and PPHN PAECs. ET-1 protein and gene expression were increased and ETB receptor protein decreased in PPHN PAECs. ET-1 siRNA, ET-1mAbs, and bosentan, but not BQ-123, increased tube formation. ROCK activity was increased in PPHN PAECs and decreased with ET-1 siRNA and bosentan treatments. Y-27632 prevented the decrease in tube formation with ET-1.
Conclusion:
ET-1 activation of ROCK impairs angiogenesis of fetal PAECs. Disruption of ET-1–ROCK interactions may increase vascular growth in PPHN.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Levin DL, Heymann MA, Kitterman JA, Gregory GA, Phibbs RH, Rudolph AM . Persistent pulmonary hypertension of the newborn infant. J Pediatr 1976;89:626–30.
Hopkins N, McLoughlin P . The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? J Anat 2002;201:335–48.
Keller RL, Tacy TA, Hendricks-Munoz K, et al. Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. Am J Respir Crit Care Med 2010;182:555–61.
Goldman AP, Tasker RC, Haworth SG, Sigston PE, Macrae DJ . Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1996;98(4 Pt 1):706–13.
Abman SH, Shanley PF, Accurso FJ . Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. J Clin Invest 1989;83:1849–58.
Gien J, Seedorf GJ, Balasubramaniam V, Markham N, Abman SH . Chronic intrauterine pulmonary hypertension impairs angiogenesis and growth of ovine fetal pulmonary artery endothelial cells in vitro. Am J Respir Crit Care Med 2007;176:1146–53.
Grover TR, Parker TA, Balasubramaniam V, Markham NE, Abman SH . Pulmonary hypertension impairs alveolarization and reduces lung growth in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 2005;288:L648–54.
Chen SJ, Chen YF, Meng QC, Durand J, Dicarlo VS, Oparil S . Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol 1995;79:2122–31.
Davie N, Haleen SJ, Upton PD et al. ETA and ETB receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 2002;165:398–405.
Miyauchi T, Yorikane R, Sakai S, et al. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 1993;73:887–97.
Ivy DD, le Cras TD, Parker TA, et al. Developmental changes in endothelin expression and activity in the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 2000;278:L785–93.
Wong J, Fineman JR, Heymann MA . The role of endothelin and endothelin receptor subtypes in regulation of fetal pulmonary vascular tone. Pediatr Res 1994;35:664–70.
Ivy DD, Ziegler JW, Dubus MF, Fox JJ, Kinsella JP, Abman SH . Chronic intrauterine pulmonary hypertension alters endothelin receptor activity in the ovine fetal lung. Pediatr Res 1996;39:435–42.
Ivy DD, Parker TA, Ziegler JW, et al. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest 1997;99:1179–86.
Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH . Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 1993;123:109–14.
Kobayashi H, Puri P . Plasma endothelin levels in congenital diaphragmatic hernia. J Pediatr Surg 1994;29:1258–61.
Zhao YD, Springall DR, Hamid Q, Levene M, Polak JM . Localization and characterization of endothelin-1 receptor binding in the blood vessels of human pulmonary tumors. J Cardiovasc Pharmacol 1995;26:Suppl 3: S336–40.
Salani D, Taraboletti G, Rosanò L, et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 2000;157:1703–11.
Arbajal JM . RhoA inactivation enhances endothelial cell barrier function. Am J Physiol 1999;277:C955–64.
McMurtry IF, Bauer NR, Fagan KA, Nagaoka T, Gebb SA, Oka M . Hypoxia and Rho/Rho-kinase signaling. Lung development versus hypoxic pulmonary hypertension. Adv Exp Med Biol 2003;543:127–37.
Parker TA, Roe G, Grover TR, Abman SH . Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 2006;291:L976–82.
Tourneux P, Chester M, Grover T, Abman SH . Fasudil inhibits the myogenic response in the fetal pulmonary circulation. Am J Physiol Heart Circ Physiol 2008;295:H1505–13.
Nagaoka T, Morio Y, Casanova N, et al. Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 2004;287:L665–72.
Oka M, Homma N, Taraseviciene-Stewart L, et al. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats. Circ Res 2007;100:923–9.
Homma N, Nagaoka T, Morio Y, et al. Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation. J Cardiovasc Pharmacol 2007;50:697–702.
Gien J, Seedorf GJ, Balasubramaniam V, Tseng N, Markham N, Abman SH . Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitro. Am J Physiol Lung Cell Mol Physiol 2008;295:L680–7.
Figueras-Aloy J, Gómez-Lopez L, Rodríguéz-Miguélez JM, et al. Plasma endothelin-1 and clinical manifestations of neonatal sepsis. J Perinat Med 2004;32:522–6.
El Sayed M, Sherif L, Said RN, El-Wakkad AS, El-Refay A, Aly H . Endothelin-1 and L-arginine in preterm infants with respiratory distress. Am J Perinatol 2011;28:129–36.
Niu JO, Munshi UK, Siddiq MM, Parton LA . Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. J Pediatr 1998;132:965–70.
Kambas K, Chrysanthopoulou A, Kourtzelis I, et al. Endothelin-1 signaling promotes fibrosis in vitro in a bronchopulmonary dysplasia model by activating the extrinsic coagulation cascade. J Immunol 2011;186:6568–75.
de Vroomen M, Lopes Cardozo RH, Steendijk P, Frölich M, Baan J, van Bel F . Endothelin-1 plasma concentration increases in the early phase of pulmonary hypertension development during respiratory distress syndrome: a study in newborn lambs. Early Hum Dev 2001;63:9–21.
Hall SM, Davie N, Klein N, Haworth SG . Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment. Eur Respir J 2011;38:851–60.
Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, Ren J . Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol 2005;145:323–33.
D’Orléans-Juste P, Claing A, Télémaque S, Maurice MC, Yano M, Gratton JP . Block of endothelin-1-induced release of thromboxane A2 from the guinea pig lung and nitric oxide from the rabbit kidney by a selective ETB receptor antagonist, BQ-788. Br J Pharmacol 1994;113:1257–62.
Jernigan NL, Walker BR, Resta TC . Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2008;295:L515–29.
Martin C, Göggel R, Ressmeyer AR, Uhlig S . Pressor responses to platelet-activating factor and thromboxane are mediated by Rho-kinase. Am J Physiol Lung Cell Mol Physiol 2004;287:L250–7.
Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P . Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res 2005;97:185–91.
Zöllner S, Aberle S, Harvey SE, Polokoff MA, Rubanyi GM . Changes of endothelial nitric oxide synthase level and activity during endothelial cell proliferation. Endothelium 2000;7:169–84.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gien, J., Tseng, N., Seedorf, G. et al. Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep. Pediatr Res 73, 252–262 (2013). https://doi.org/10.1038/pr.2012.177
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/pr.2012.177
This article is cited by
-
Challenges, priorities and novel therapies for hypoxemic respiratory failure and pulmonary hypertension in the neonate
Journal of Perinatology (2016)
